Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma.

Standard

Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma. / Jehan, Zeenath; Siraj, Abdul K; Abubaker, Jehad; Ruiz, Christian; Simon, Ronald; Sultana, Mehar; Uddin, Shahab; Bavi, Prashant; Hussain, Azhar; Razack, Shirin; Ezzat, Adnan; Al-Dayel, Fouad; Sauter, Guido; Al-Kuraya, Khawla S.

In: ONCOLOGY-BASEL, Vol. 75, No. 1-2, 1-2, 2008, p. 71-80.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Jehan, Z, Siraj, AK, Abubaker, J, Ruiz, C, Simon, R, Sultana, M, Uddin, S, Bavi, P, Hussain, A, Razack, S, Ezzat, A, Al-Dayel, F, Sauter, G & Al-Kuraya, KS 2008, 'Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma.', ONCOLOGY-BASEL, vol. 75, no. 1-2, 1-2, pp. 71-80. <http://www.ncbi.nlm.nih.gov/pubmed/18784434?dopt=Citation>

APA

Jehan, Z., Siraj, A. K., Abubaker, J., Ruiz, C., Simon, R., Sultana, M., Uddin, S., Bavi, P., Hussain, A., Razack, S., Ezzat, A., Al-Dayel, F., Sauter, G., & Al-Kuraya, K. S. (2008). Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma. ONCOLOGY-BASEL, 75(1-2), 71-80. [1-2]. http://www.ncbi.nlm.nih.gov/pubmed/18784434?dopt=Citation

Vancouver

Jehan Z, Siraj AK, Abubaker J, Ruiz C, Simon R, Sultana M et al. Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma. ONCOLOGY-BASEL. 2008;75(1-2):71-80. 1-2.

Bibtex

@article{90c4b1129b49440fb43f1c4ab4d9a717,
title = "Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma.",
abstract = "INTRODUCTION: Approximately one third of diffuse large B-cell lymphomas (DLBCL) arises from tissues different from the lymph node. Perceived differences in outcome between extranodal and nodal DLBCL raise the possibility that these subgroups may represent different biological and clinical entities. METHODS: Microarray GeneChip technology was used for global gene expression profiles from nodal (n = 19) and extranodal (n = 8) DLBCL, to examine possible differences between these subgroups. Quantitative RT-PCR was employed for validation of microarray data. Differential expression levels of p16 (CDKN2A) were confirmed by means of immunohistochemistry on a tissue microarray comprising more than 200 lymphoma samples. RESULTS: A total of 218, over (124)- and underexpressed (94) genes were found to be differentially expressed in extranodal DLBCL compared with nodal DLBCL, including cytokines/chemokines, chromosome-replication-related genes and DNA repair genes. Quantitative RT-PCR confirmed the microarray data. A higher rate of p16 positivity was found in extranodal lymphomas. However, prognostic importance of p16 was associated with nodal rather than extranodal lymphomas. CONCLUSION: Our data suggest that a better distinction of these subgroups based on molecular classifiers is feasible and may greatly facilitate the determination of specific relevant clinical features and therapeutic implications of DLBCL with primary extranodal or nodal location.",
author = "Zeenath Jehan and Siraj, {Abdul K} and Jehad Abubaker and Christian Ruiz and Ronald Simon and Mehar Sultana and Shahab Uddin and Prashant Bavi and Azhar Hussain and Shirin Razack and Adnan Ezzat and Fouad Al-Dayel and Guido Sauter and Al-Kuraya, {Khawla S}",
year = "2008",
language = "Deutsch",
volume = "75",
pages = "71--80",
journal = "ONCOLOGY-BASEL",
issn = "0030-2414",
publisher = "S. Karger AG",
number = "1-2",

}

RIS

TY - JOUR

T1 - Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma.

AU - Jehan, Zeenath

AU - Siraj, Abdul K

AU - Abubaker, Jehad

AU - Ruiz, Christian

AU - Simon, Ronald

AU - Sultana, Mehar

AU - Uddin, Shahab

AU - Bavi, Prashant

AU - Hussain, Azhar

AU - Razack, Shirin

AU - Ezzat, Adnan

AU - Al-Dayel, Fouad

AU - Sauter, Guido

AU - Al-Kuraya, Khawla S

PY - 2008

Y1 - 2008

N2 - INTRODUCTION: Approximately one third of diffuse large B-cell lymphomas (DLBCL) arises from tissues different from the lymph node. Perceived differences in outcome between extranodal and nodal DLBCL raise the possibility that these subgroups may represent different biological and clinical entities. METHODS: Microarray GeneChip technology was used for global gene expression profiles from nodal (n = 19) and extranodal (n = 8) DLBCL, to examine possible differences between these subgroups. Quantitative RT-PCR was employed for validation of microarray data. Differential expression levels of p16 (CDKN2A) were confirmed by means of immunohistochemistry on a tissue microarray comprising more than 200 lymphoma samples. RESULTS: A total of 218, over (124)- and underexpressed (94) genes were found to be differentially expressed in extranodal DLBCL compared with nodal DLBCL, including cytokines/chemokines, chromosome-replication-related genes and DNA repair genes. Quantitative RT-PCR confirmed the microarray data. A higher rate of p16 positivity was found in extranodal lymphomas. However, prognostic importance of p16 was associated with nodal rather than extranodal lymphomas. CONCLUSION: Our data suggest that a better distinction of these subgroups based on molecular classifiers is feasible and may greatly facilitate the determination of specific relevant clinical features and therapeutic implications of DLBCL with primary extranodal or nodal location.

AB - INTRODUCTION: Approximately one third of diffuse large B-cell lymphomas (DLBCL) arises from tissues different from the lymph node. Perceived differences in outcome between extranodal and nodal DLBCL raise the possibility that these subgroups may represent different biological and clinical entities. METHODS: Microarray GeneChip technology was used for global gene expression profiles from nodal (n = 19) and extranodal (n = 8) DLBCL, to examine possible differences between these subgroups. Quantitative RT-PCR was employed for validation of microarray data. Differential expression levels of p16 (CDKN2A) were confirmed by means of immunohistochemistry on a tissue microarray comprising more than 200 lymphoma samples. RESULTS: A total of 218, over (124)- and underexpressed (94) genes were found to be differentially expressed in extranodal DLBCL compared with nodal DLBCL, including cytokines/chemokines, chromosome-replication-related genes and DNA repair genes. Quantitative RT-PCR confirmed the microarray data. A higher rate of p16 positivity was found in extranodal lymphomas. However, prognostic importance of p16 was associated with nodal rather than extranodal lymphomas. CONCLUSION: Our data suggest that a better distinction of these subgroups based on molecular classifiers is feasible and may greatly facilitate the determination of specific relevant clinical features and therapeutic implications of DLBCL with primary extranodal or nodal location.

M3 - SCORING: Zeitschriftenaufsatz

VL - 75

SP - 71

EP - 80

JO - ONCOLOGY-BASEL

JF - ONCOLOGY-BASEL

SN - 0030-2414

IS - 1-2

M1 - 1-2

ER -